dsm-firmenich and Inscripta Announce Strategic Partnership to Drive Biotech Innovations in Well-Aging Skincare

April 4, 2025

dsm-firmenich, innovators in nutrition, health, and beauty, and biotechnology company Inscripta^® are pleased to announce a strategic partnership in the beauty industry. This science-driven collaboration, goes beyond wellbeing, creating groundbreaking skin care solutions that bring to consumers elevated moments of care, and superior consumer delight – all with a positive impact on people and planet. The partnership will focus on a novel, highly sought-after well-aging skin care ingredient, and the combined expertise of the two companies will enable the exploration of additional opportunities to bring biotech innovations to the global market.

With over 150 years of scientific innovation, dsm-firmenich leads the beauty industry in advancing skincare through biotechnology: “Our deep expertise in biotechnology is a key driver of innovation, enabling us to deliver new-to-the-world ingredients, improve our existing solutions, and provide a consistent supply to our businesses,” said Sarah Reisinger, Chief Science and Research Officer at dsm-firmenich. “Biotechnology is also helping us make our solutions more sustainable, supporting important moves towards eco-conscious beauty. We are excited about the new possibilities we can unlock by combining Inscripta’s cutting-edge biotech tools and expertise with our own.”

Combining deep expertise in biotech with a strong understanding of consumer needs, the company is driving the transformation of the beauty sector. Recognized as a leader, dsm-firmenich won the prestigious in-cosmetics 2024 Innovation Award for its ETERWELL^™ YOUTH bio-active. Their commitment to sustainability and eco-conscious beauty solutions ensures they are well-positioned to meet the growing global demand for sustainable products. With expertise spanning classical and modern biotech, dsm-firmenich’s global team of experts brings unmatched biotech strength. The company has pioneered products like OXY 229 CB, REGU^®-AGE CB, ALPHA-ARBUTIN, and HYALURONIC ACID-BT, further solidifying its role as a trailblazer in biotech-driven beauty innovations.

“As leaders in biotechnology, at dsm-firmenich we are thrilled to collaborate with Inscripta, a well-respected innovator in biotech strain engineering,” said Parand Salmassinia, President of Beauty & Care at dsm-firmenich. “By integrating Inscripta’s scientific knowledge with our biotechnology skincare expertise, we’re set to deliver next-generation well-aging products that offer superior results while contributing to a more sustainable future. Our biotech leadership will ensure that we not only meet consumer expectations but exceed them”.

Inscripta develops innovative and sustainable biomanufacturing solutions for a variety of applications and industries beyond beauty, including agriculture, chemicals, animal and human health solutions, and pharmaceuticals. Through this complementary partnership, Inscripta will bring its expertise in microbial strain engineering using its proprietary GenoScaler^™ platform—a next-generation technology which leverages proprietary whole genome engineering to deliver robust industrial scale bio-manufacturing. Inscripta delivers specialty ingredients at manufacturing scale capable of meeting the high-quality standards of commercial partners like dsm-firmenich.

“Partnering with dsm-firmenich allows us to demonstrate the full potential of biotechnology in the beauty industry,” said Sri Kosaraju, President and CEO at Inscripta. “Our GenoScaler platform, combined with dsm-firmenich’s vast experience in biotech, presents new opportunities for creating bio-active ingredients that meet the high-performance standards of today’s skincare market, while also addressing the growing demand for sustainability.”

The collaboration between dsm-firmenich and Inscripta combines scientific innovation and environmental responsibility to drive rapid, cost-effective solutions for customers. This partnership ensures supply chain security, scalability, consistent quality, and efficient use of natural resources. As demand for eco-friendly solutions grows, it has the potential to deliver a new generation of skincare innovations by combining dsm-firmenich and Inscripta biotechnology and skincare expertise.

dsm-firmenich
We bring progress to life

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion.

Beauty & Care Global Marketing Communications
beautycare.communications@dsm-firmenich.com
www.dsm-firmenich.com
Beauty & Care
LinkedIn | X | Instagram | Facebook

About Inscripta^®

Inscripta develops innovative, sustainable, and affordable biomanufacturing solutions for a variety of applications and industries, including agriculture, chemicals, animal and human health solutions, personal care, and pharmaceuticals.

Inscripta uses GenoScaler^™, a proprietary next-generation microbial strain engineering platform based on over 200 patents and relying on ultra-high-throughput CRISPR+ technologies and cutting-edge artificial intelligence and machine learning tools, to manufacture and supply ingredients at scale under rapid timelines. Founded in 2015, Inscripta is headquartered in Pleasanton, CA, USA.

For more information, visit www.Inscripta.com.

Inscripta Communications
press@inscripta.com
www.inscripta.com
LinkedIn